A new deep learning framework developed by researchers from Contextvision, a medical technology company based in Sweden, can help doctors identify and segment lung cancer. ��The microscopic evaluation of cancer is the cornerstone of clinical diagnostics, and particularly in lung cancer where the evaluation is highly dependent on the experience of a pathologist. The evaluation can vary��
]]>